Hormone Resistant Prostate Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Castration Levels of Testosterone; Hormone-Resistant Prostate Cancer; Microsatellite Instability Interventions: Biological: Durvalumab; Other: Laboratory Biomarker Analysis Sponsors: University of Washington; National Cancer Institute (NCI) Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2016 Category: Research Source Type: clinical trials
